CKPT - Checkpoint Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
72.24M
Enterprise Value 3
59.18M
Trailing P/E
N/A
Forward P/E 1
-3.20
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
15.32
Price/Book (mrq)
11.52
Enterprise Value/Revenue 3
12.55
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 3.01
52-Week Change 3-42.06%
S&P500 52-Week Change 325.78%
52 Week High 35.2000
52 Week Low 31.1200
50-Day Moving Average 31.5509
200-Day Moving Average 32.1100

Share Statistics

Avg Vol (3 month) 3267.56k
Avg Vol (10 day) 3276.33k
Shares Outstanding 531.22M
Float 27.15M
% Held by Insiders 133.49%
% Held by Institutions 112.40%
Shares Short (Dec 30, 2019) 4576.69k
Short Ratio (Dec 30, 2019) 41.83
Short % of Float (Dec 30, 2019) 42.55%
Short % of Shares Outstanding (Dec 30, 2019) 41.51%
Shares Short (prior month Nov 28, 2019) 4435.46k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-591.54%

Management Effectiveness

Return on Assets (ttm)-77.66%
Return on Equity (ttm)-194.48%

Income Statement

Revenue (ttm)4.71M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)5,500.00%
Gross Profit (ttm)-30.15M
EBITDA N/A
Net Income Avi to Common (ttm)-27.51M
Diluted EPS (ttm)-0.8420
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.06M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.80
Book Value Per Share (mrq)0.16

Cash Flow Statement

Operating Cash Flow (ttm)-24.25M
Levered Free Cash Flow (ttm)-16.12M